Barchart.com
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Menu
alerts false
Stocks | Futures | Watchlist | News | More
 
Advanced search
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Geovax Labs (GOVX)

Geovax Labs (GOVX)
0.9800 x 48 1.0000 x 2
Post-market by (Cboe BZX)
1.0000 +0.1520 (+17.92%) 04/24/25 [NASDAQ]
0.9800 x 48 1.0000 x 2
Post-market 0.9999 -0.0001 (-0.01%) 18:29 ET
News & Headlines for Thu, Apr 24th, 2025
Notes
Alerts
Watch
    Add or delete the symbol from one or more Watchlists.
  • Create New Watchlist
    This name already in use.
Help
Go To:
World Cancer Day Sparks Big Questions About Pollution, Genetics, and Innovation BayStreet.ca - Thu Feb 27, 8:58AM CST

Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – USA News Group News Commentary – As World Cancer Day (Feb. 4) fades into the rearview, attention is shifting to the latest discussions...

ONCY : 0.5833 (+2.95%)
ZNTL : 1.5100 (+0.67%)
NYT : 50.61 (+0.34%)
ABSI : 3.22 (+0.94%)
GOVX : 1.0000 (+17.92%)
ONC.TO : 0.81 (+2.53%)
GSK : 37.50 (+1.27%)
New Vaccine Technologies Lead the Charge as Global Immunization Efforts Evolve BayStreet.ca - Wed Dec 18, 2024

Issued on behalf of BioVaxys Technology Corp. VANCOUVER – USA News Group – According to the World Health...

PCVX : 34.51 (+4.07%)
BVAXF : 0.0321 (+12.24%)
BIOV.CN : 0.0400 (unch)
GILD : 106.15 (-0.22%)
GOVX : 1.0000 (+17.92%)
ARCT : 12.89 (+1.90%)
GeoVax Labs, Inc. Secures U.S. Patent Notice of Allowance for Tumor Immunotherapy Technology Quiver Quantitative, Inc. - Mon Dec 9, 2024

GeoVax Labs receives patent allowance, enhancing its intellectual property for cancer immunotherapy using its unique viral vector platform.Quiver AI SummaryGeoVax Labs, Inc. announced that the U.S. Patent...

GOVX : 1.0000 (+17.92%)
Author
3 Penny Stocks Ready to Break Out in 2025 MarketBeat - Fri Nov 29, 2024

Vuzix, GeoVox Labs, and Cardiol Therapeutics emerged as notable penny stocks late in 2024 for their potential to scale operations and launch new products.

VUZI : 1.8300 (+7.02%)
CRDL : 1.0700 (-0.93%)
GOVX : 1.0000 (+17.92%)
GeoVax Labs, Inc. CEO David Dodd to Present at NobleCon20 Conference Quiver Quantitative, Inc. - Tue Nov 26, 2024

GeoVax Labs announces CEO David Dodd will present at NobleCon20 on corporate updates and clinical trials.Quiver AI SummaryGeoVax Labs, Inc., a biotechnology company focused on human vaccines and cancer...

GOVX : 1.0000 (+17.92%)
GeoVax, SIGA Jump After WHO Extends Mpox Public Emergency Status: Here’s What Retail Thinks Stocktwits - Fri Nov 22, 2024

Emergent Biosolutions and Chimerix also saw marginal gains after the announcement.

SIGA : 6.48 (+3.85%)
EBS : 5.37 (+7.83%)
GOVX : 1.0000 (+17.92%)
CMRX : 8.54 (-0.12%)
Pancreatic Cancer Market Is Projecting to Expand As NCI-Funded Research Expects to Empower Market Growth FinancialNewsMedia - Thu Jun 20, 2024

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:GOVX),(NYSE:GSK),(NASDAQ:AZN),(NYSE:MRK) EQNX::TICKER_END

ONCY : 0.5833 (+2.95%)
AZN : 69.55 (+1.52%)
MRK : 79.84 (+1.40%)
GOVX : 1.0000 (+17.92%)
ONC.TO : 0.81 (+2.53%)
GSK : 37.50 (+1.27%)
Pancreatic Cancer Market Is Projecting to Expand As NCI-Funded Research Expects to Empower Market Growth GlobeNewswire - Thu Jun 20, 2024

ONCY : 0.5833 (+2.95%)
AZN : 69.55 (+1.52%)
MRK : 79.84 (+1.40%)
GOVX : 1.0000 (+17.92%)
ONC.TO : 0.81 (+2.53%)
GSK : 37.50 (+1.27%)
GeoVax Reports 2022 Second Quarter Financial Results and Provides Corporate Update Globe Newswire - Wed Aug 3, 2022

Advancing Phase 2 Clinical Trials for COVID-19 and Immuno-Oncology Evaluation of Company’s Vaccine Platform Against Monkeypox Underway ATLANTA, GA,...

GOVXW : 0.0388 (+29.33%)
GOVX : 1.0000 (+17.92%)
GeoVax Announces Peer-Reviewed Publication in NPJ Vaccines of Preclinical Data for Vaccine Candidate Against Sudan Ebolavirus Showing 100% Protection With a Single Immunization Globe Newswire - Thu Jul 28, 2022

ATLANTA, GA, July 28, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing human vaccines and...

GOVXW : 0.0388 (+29.33%)
GOVX : 1.0000 (+17.92%)

Barchart Exclusives

Grain Rally Mystery: Why Are Soybeans, Corn, and Wheat Bucking the Trend? Barchart - 1 hour ago
In an interview on AgWeb's Markets Now, Darin Newsom of Barchart discussed the surprising grain market rally led by soybeans despite negative China trade news, a potential corrective bounce in corn with weak basis, and a likely bear trap in wheat, while also touching on the bullish cattle market's connection to equities and a potential shift out of stocks into safer assets. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Value Investing Philosophies: Graham, Buffett, Bogle, and EMH in Perspective
Wed, Apr 30, 2025 5:00 PM UTC
Reserve Your Spot